Santen maintains relationships with policy makers,
health authorities, health professionals and patient associations. These
activities are based on the transparency and the quality of the
information. They meet the standards and principles in force. Only those
employees of the company and duly authorized for this purpose may
conduct such activities.
Clinical development is an
important phase in the development of products and solutions which
ensure good tolerability and efficacy. Our transparency requirements
apply to all stages of clinical trials.
focuses on improving the quality of life of patients and their loved
ones. We encourage in active dialogue with them to listen and learn to
better understand their disease and to develop safe and innovative
solutions and products.
To achieve this commitment we
build relationships with patient organizations and the persons
accompanying them and defending their rights and interests. These
relationships are based on mutual respect, trust and transparency.
is committed to improve the patients' quality of life. To this end we
have developed relationships with healthcare professionals, experts and
researchers specialized in ophthalmology and all scientific fields that
allow us to develop safe and effective solutions and products.
relationships allow us to listen and learn from them at all stages of
development and manufacturing to meet their needs and accelerate the
access to innovations that will benefit the patients.
development of our products follows international standards and local
regulations. Santen ensures that all clinical trials comply with these
standards and is committed to: